Concepedia
Statistics
Publications
20
Citations
4K
H-Index
15
Active since
2011
Affiliations
Inova Fairfax Hospital(Current)
Gilead Sciences (United States)
Pinnacle Clinical Research
Amgen (United States)
The University of Texas at San Antonio Health Science Center
Catherine Jia is an author at Inova Fairfax Hospital specializing in medicine, liver disease, and hepatology.
Publications per year
2011–2022
Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
Max S. Topp, Nicola Gökbuget, Anthony S. Stein et al. · The Lancet Oncology · 2014 · 1.3K citations
Medicine, Hematology, Oncology +13
Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials
Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 466 citations
Medicine, Internal Medicine, Pharmacotherapy +12
The Natural History of Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Data From the Simtuzumab Trials
Arun J. Sanyal, Stephen A. Harrison, Vlad Ratziu et al. · Hepatology · 2019 · 389 citations
Medicine, Pathology, Pharmacotherapy +17
Simtuzumab Is Ineffective for Patients With Bridging Fibrosis or Compensated Cirrhosis Caused by Nonalcoholic Steatohepatitis
Stephen A. Harrison, Manal F. Abdelmalek, Stephen H. Caldwell et al. · Gastroenterology · 2018 · 372 citations
Medicine, Internal Medicine, Pharmacology +13
Combination Therapies Including Cilofexor and Firsocostat for Bridging Fibrosis and Cirrhosis Attributable to NASH
Rohit Loomba, Mazen Noureddin, Kris V. Kowdley et al. · Hepatology · 2020 · 278 citations
Medicine, Pharmacology, Pharmacotherapy +17
1–5 of 20